PREDICTION OF RECURRENCE FOR BLADDER CANCER BY A PROTEIN SIGNATURE IN TISSUE SAMPLES
    2.
    发明申请
    PREDICTION OF RECURRENCE FOR BLADDER CANCER BY A PROTEIN SIGNATURE IN TISSUE SAMPLES 有权
    通过组织样品中的蛋白质标志预测刮板癌的复发

    公开(公告)号:US20140193927A1

    公开(公告)日:2014-07-10

    申请号:US14124580

    申请日:2012-06-08

    IPC分类号: G01N33/574

    摘要: The present invention pertains to the field of cancer prediction. Specifically, it relates to a method for predicting the risk of recurrence of bladder cancer in a subject after treatment of bladder cancer comprising the steps of determining the amount of at least one biomarker selected from the biomarkers shown in Table, and comparing the amount of said at least one biomarker with a reference amount for said at least one biomarker, whereby the risk of recurrence of bladder cancer is to be predicted. The present invention also contemplates a method for identifying a subject being in need of a further bladder cancer therapy. Encompassed are, furthermore, diagnostic devices and kits for carrying out said methods.

    摘要翻译: 本发明涉及癌症预测领域。 具体地说,本发明涉及一种用于预测膀胱癌治疗后受试者膀胱癌复发风险的方法,包括以下步骤:确定选自表中所示生物标志物的至少一种生物标志物的量,并比较所述 至少一种具有所述至少一种生物标志物的参考量的生物标志物,由此预测膀胱癌复发的风险。 本发明还考虑了用于鉴定需要进一步膀胱癌治疗的受试者的方法。 此外,还包括用于执行所述方法的诊断装置和试剂盒。